Pediatric Hematology / Oncology

The Division of Pediatric Hematology/Oncology has an outstanding tradition of achievement in patient care and research in Pediatric Hematology/Oncology and Blood and Marrow Transplantation. 

Clinical Care

Our program is renowned for our expertise in malignant and non-malignant blood disorders and solid tumors including brain tumors in children, adolescents and young adults.  In addition, the members of the Division have provided unique services in the area of treatment of neuroblastomalymphomas, and brain tumors. National clinical research protocols have been developed at the University of Michigan for the treatment of refractory neuroblastoma, graft-versus-host-disease, and adaptive cellular therapy of leukemia and lymphoma using stem cell transplantation.

Dr Rajen Mody

Rajen Mody, M.D.
Director, Hematology/Oncology


The Division is proud of the achievements in basic research including programsdevoted towards understanding the biology of phagocytosis and generation of myeloid cells. Other research studies are designed to provide novel gene therapeutic approaches for treatment of hemophilia. Other research involves mechanisms of globin switching, pathogenesis of leukemia and neuroblastoma, immune therapy of leukemias, lymphomas, solid tumors, and B-cell signalling.

Our Division currently holds an NIH-supported Hematology Training Grant, which has been awarded to only three programs in the country. Additionally, the Division enjoys the largest continuing support from the National Institutes of Health within the Department of Pediatrics. A number of our faculty members have been recognized over the years by being selected as the Best Doctors in America .

Contact Phone Numbers

General Information: 734-936-9814

Fax: 734-647-8664

Mailing Address

Division of Pediatric Hematology/Oncology

1500 East Medical Center Drive

B1-358 CGC Reception B

Ann Arbor, MI 48109-5910